VENTRITEX CADENCE 110 IS APPROVABLE
This article was originally published in The Gray Sheet
Executive Summary
VENTRITEX CADENCE 110 IS APPROVABLE, company President and CEO Frank Fischer announced at a May 12 session of the Alex. Brown annual Health Care Seminar in Baltimore. The firm received the approvable letter from FDA in April, and expects final approval of the implantable cardioverter defibrillator in the third quarter. A premarket approval application supplement for the device was submitted in mid-October.